Table 1

 Demographic features of patients with RA at baseline

CharacteristicsEtanercept (n = 12)Adalimumab (n = 7)
Sex
    Men, No (%)4 (33)1 (14)
    Women, No (%)8 (67)6 (86)
Age (years), mean (SD)60 (7)53 (12)
Disease duration (years), mean (SD)13 (6)10 (7)
DMARDs before TNFα blocker (n), mean (SD)5 (2)5 (3)
Previous DMARDs (n)
    Methotrexate127
    Hydroxychloroquine54
    Sulfasalazine56
    Ciclosporin A52
    Gold (intramuscular)41
    Gold (oral)42
    Leflunomide65
    Azathioprine10